The weight-loss drug market is evolving at a rapid speed, with leading pharma companies including Novo Nordisk and Eli Lilly ...
Touch a hot plate and your hand flies back. While the response is almost instant, researchers are still working to better ...
On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...
Metabolic diseases, encompassing obesity, diabetes, cardiovascular conditions, nonalcoholic fatty liver disease, hypertension, and metabolic syndrome, are ...
Transgender Mice refers to a viral debate and discourse about a segment in President Donald Trump's address to the joint ...
A phase 1/2 trial is evaluating HLD-0915, a novel oral therapy, for metastatic castration-resistant prostate cancer in up to ...
K. Sadasivan Pillai Wednesday, March 5, 2025, 08:00 Hrs [IST] ...
Keven Williams says a private health check-up did not detect his cancer. By the time he was diagnosed two years later, it had ...
Basketball Network on MSN6d
"There are stuff on the banned substances list that don't need to be there" - Brunson and Hart share thoughts on Bobby Portis' suspensionIt's usually not steroids or performance enhancers but substances that players claim they had no idea were banned. That's the ...
Phase 2 data support the use of SBRT in patients with CRPC who have 1-5 metastatic sites, according to researchers.
The first patient has been dosed in a first-in-human clinical trial evaluating HLD-0915 for metastatic castration-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback